Baylor Scott & White The Heart Hospital
Advancing heart health through expertise and innovation
Every year, our quality outcomes shine through in the tens of thousands of hearts like yours that find healing and hope at Baylor Scott & White The Heart Hospital. From the beginning, we’ve put quality at the core of our approach to care—consistently exceeding goals and earning national recognition for our patient outcomes.
Our network of Baylor Scott & White The Heart Hospitals includes teams performing high volumes of complex procedures and providers who are actively involved in leading research, publications and presentations that are guiding the standards for heart and vascular care.
We’re involved in 24 cardiovascular registry modules to share and track outcomes, more than 170 industry trials and perform 35,000+ procedures a year. But these stats are more than just numbers to us—they represent hearts healed and lives saved, creating a new path forward for people across the nation.
Cardiac surgery STS ratings
With a 3-star rating—the highest possible—in all six cardiac surgery categories from the Society of Thoracic Surgeons (STS), our Plano heart hospital is among the top 1% nationally in cardiac surgery outcomes. Our heart hospital in Denton has also earned a 3-star rating in two cardiac surgery categories.
Our 3-star ratings include:
- Coronary artery bypass surgery (Denton and Plano)
- Aortic valve replacement (Plano)
- Aortic valve replacement + coronary artery bypass surgery (Plano)
- Mitral valve repair/replacement (Plano)
- Mitral valve repair/replacement + coronary artery bypass surgery (Plano)
- Multi-procedural (Denton and Plano)
Outcomes
Data-driven, evidence-based decisions help us provide exceptional care. Baylor Scott & White The Heart Hospital tracks outcomes across numerous disciplines, procedures and locations and continuously works to improve the care we provide. Our outcomes data not only guides our team but also provides you with the information you need to make the best choices for your heart and vascular health.
| Procedure | Volume at all locations | Mortality* (lower is better) |
|---|---|---|
| Percutaneous coronary intervention (PCI) Procedure to place stents and open blocked arteries in the heart |
>4,600 | 1% (compared to 1.9% nationally) |
| PCI with enhanced imaging guidance | Over 60% of cases (compared to 20% nationally) | |
| Chronic total occlusion When one of the arteries in the heart is completely blocked |
350+ | 0.8% |
*Data period: April 2024–March 2025
| Procedure | Plano and Denton volumes | Plano mortality (lower is better) | Denton mortality (lower is better) | STS overall predicted mortality |
|---|---|---|---|---|
| Mitral valve repair or replacement and coronary artery bypass surgery (MVRR + CABG) Procedure to fix the mitral valve and bypass blocked arteries in the heart |
120 | |||
| Aortic valve replacement and coronary artery bypass surgery (AVR + CABG) Procedure to replace the aortic valve and bypass blocked arteries in the heart |
248 | 0% | 0% | 3.6% |
| Aortic valve replacement (AVR) Procedure to replace the aortic valve in the heart |
347 | 0% | 0% | 1.76% |
| Mitral valve repair or replacement (MVRR) Procedure to fix the mitral valve in the heart |
778 | 0% (repair) 0.0175 (replacement) |
0.93% (repair) 4.87% (replacement) |
|
| Coronary artery bypass surgery (Isolated CABG) Procedure to bypass blocked arteries in the heart |
2,780 | 0.66% | 2.09% | 2.05% |
| Multiprocedural Combined data from multiple surgical procedures |
4,492 | |||
| Cardiac robotic procedures (March 2024-February 2025) |
239 |
| Procedure | Volume | Mortality (lower is better) |
|---|---|---|
| Lobectomy Removes an entire lung lobe |
21 | 0% |
| Segmentectomy Removes a segment of the lung |
32 | 0% |
| Wedge Removes a small piece of lung tissue |
51 | 0% |
| Procedure | Volume | Mortality*** (lower is better) |
|---|---|---|
| Transcatheter aortic valve replacement (TAVR) Replaces the aortic valve without open surgery |
724 (FY25) | 0.7% (compared to 1% nationally) |
| Mitral transcatheter edge-to-edge repair (M-TEER)* Minimally invasive treatment for mitral valve regurgitatione |
107 (FY25) | 0% (compared to 1.5% nationally) |
| Transcatheter tricuspid valve replacement (TTVR)** Replaces the tricuspid valve without open surgery |
0 | 0% (compared to 1.5% nationally) |
*Dallas, Plano and Fort Worth
**Dallas and Plano
***Data period: March 2024–February 2025
| Procedure | Volume | Mortality* (lower is better) |
|---|---|---|
| Carotid stent Places a stent to open a blocked artery in the neck |
224 | 0.4% |
| Carotid endarterectomy Surgically removes plaque from the artery in the neck to reduce the risk of stroke |
159 | 1.3% |
| Endovascular abdominal aortic aneurysm (AAA) repair Minimally invasive repair of an aneurysm in the body’s largest artery |
95 | 0% |
| Open abdominal aortic aneurysm (AAA) repair Traditional surgical repair of an aneurysm in the body’s largest artery |
11 | 0% |
| Thoracic endovascular aortic repair (TEVAR) Minimally invasive repair of an aneurysm in the upper part of the aorta |
91 | 0% |
*Data period: April 2024–March 2025
| Procedure | Volume | Stroke rate* (lower is better) |
|---|---|---|
| Ross procedure Replaces your aortic valve with your own pulmonary valve and replaces your pulmonary valve with a donor valve |
26 | 0% |
| Bentall bioprosthetic Replaces the ascending aorta, aortic root and aortic valve using animal tissue |
65 | 0% |
| Bentall homograft Replaces the ascending aorta, aortic root and aortic valve using human tissue |
6 | 0% |
| Bentall mechanical Replaces the ascending aorta, aortic root and aortic valve using synthetic materials |
19 | 0% |
| David/Yacoub procedure Replaces the aortic root but not the aortic valve |
44 | 0% |
| Root reconstruction Repairs an aneurysm in the aortic root |
20 |
*Data period: March 2024–February 2025
| Procedure | Volume* |
|---|---|
| Pacemaker Implants a device to regulate your heart’s electrical system |
2,078 |
| Left atrial appendage occlusion Used to reduce the risk of stroke in those with atrial fibrillation |
1,140 |
| Implantable cardioverter defibrillator (ICD) Implants a device to reduce the risk of sudden cardiac arrest |
1,079 |
| Ablation Freezes or burns small areas of the heart related to irregular rhythms |
4,189 |
*Data period: April 2024 – March 2025
| Procedure | Survival* (higher is better) |
|---|---|
| Cardiac ECMO Use in people with life-threatening heart failure or conditions |
59% (compared to 47% nationally) |
| Pulmonary ECMO Use in people with life-threatening lung failure or conditions |
78% (compared to 59% nationally) |
| Extracorporeal cardiopulmonary resuscitation (ECRP) Used for cardiac arrest that doesn’t respond to other treatments |
44% (compared to 31% nationally) |
| Right ventricular assist device (RVAD) Used to treat right ventricular failure |
70% (compared to 47% nationally) |
| Procedure | Volume |
|---|---|
| Cardiac MRI | 5,696 |
| Cardiac CT | 31,513 |
| Echocardiograms | 73,049 |
| Metric | Volume* |
|---|---|
| New patients | 2,860 |
| Outpatient treatments | 51,438 |
| Inpatient visits | 13,935 |
*Denton, Dallas, Fort Worth, Plano and Waxahachie: May 2024 - April 2025